For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Cardea Bio, Inc.

USPTO Granted Patents = 12

CIPO Patents = 1

EPO Patents = 2

Trademarks = 5

Forward Citations = 15

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Brett R Goldsmith (12 out of 26 patents)

Mitchell Lerner (6 out of 19 patents)

Paul Robert Hoffman (6 out of 48 patents)

4. Pieter Van Rooyen (2 out of 151 patents)

5. Kiana Aran (2 out of 6 patents)

6. Alexander Kane (2 out of 3 patents)

7. Regis Peytavi (2 out of 2 patents)

8. Deng Pan (1 out of 5 patents)

12 patents: Sort by Forward Citations

1. 12372521 - Chemically differentiated sensor array (2025-07-29),

2. 12345677 - Integrated circuit with 2D FETs for direct and indirect target signal measurement (2025-07-01),

3. 12298301 - Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same (2025-05-13),

4. 11782057 - Ic with graphene fet sensor array patterned in layers above circuitry formed in a silicon based cmos wafer (2023-10-10),

5. 11732296 - Two-dimensional channel FET devices, systems, and methods of using the same for sequencing nucleic acids (2023-08-22),

6. 11713455 - Enhanced selection of efficient targeted genome manipulating agents (2023-08-01),

7. 11536722 - Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same (2022-12-27),

8. 11215580 - System and method for DNA sequencing and blood chemistry analysis (2022-01-04),

9. 11092598 - Chemically differentiated sensor array (2021-08-17),

10. 11056343 - Providing a temporary protective layer on a graphene sheet (2021-07-06),

11. 11016088 - Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same (2021-05-25),

12. 10968481 - Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids (2021-04-06),

Cardea Bio is a biotechnology company focused on developing cutting-edge solutions for the life sciences industry. With expertise in CRISPR technology and synthetic biology, Cardea Bio is revolutionizing the way researchers and scientists approach genetic engineering and gene editing. Through innovative products and services, Cardea Bio is paving the way for advancements in personalized medicine, agriculture, and beyond.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

12 Patents

#423 in San Diego, CA

#5,886 in California

#24,841 in US

#46,762 in the World

San Diego, CA, United States of America

Cardea Bio, Inc.

Forward Citations = 15

8 inventors:

Brett R Goldsmith (12 out of 26 patents)

Mitchell Lerner (6 out of 19 patents)

Paul Robert Hoffman (6 out of 48 patents)

4. Pieter Van Rooyen (2 out of 151 patents)

5. Kiana Aran (2 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…